Question 1

Who is Joseph E. Smith?

Accepted Answer

Joseph E. Smith serves as Executive at PAR PHARMACEUTICAL COMPANIES, INC. (PRX). They have executed 44 insider transactions totaling $5.7M over their tenure at the company.

Question 2

What is Joseph E. Smith's role at PAR PHARMACEUTICAL COMPANIES, INC.?

Accepted Answer

Joseph E. Smith holds the position of Executive at PAR PHARMACEUTICAL COMPANIES, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.

Question 3

Is Joseph E. Smith buying or selling PRX stock?

Accepted Answer

Joseph E. Smith has shown a selling trading pattern, with $922.5K in total purchases and $4.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Joseph E. Smith's largest insider transactions?

Accepted Answer

The largest transaction by Joseph E. Smith was on Sep 28, 2012, when they sold $3.5M worth of PRX shares. This transaction involved 70,000 shares at $50.00 per share.

Question 5

What is Joseph E. Smith's trading accuracy?

Accepted Answer

Joseph E. Smith has a Personal Accuracy Score of 91/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Joseph E. Smith associated with?

Accepted Answer

Joseph E. Smith has filed Form 4 transactions for 3 different companyies. Their primary association is with PAR PHARMACEUTICAL COMPANIES, INC. (PRX), where they serve as Executive.

Question 7

How much PRX stock does Joseph E. Smith own?

Accepted Answer

Joseph E. Smith currently owns 23,921 shares of PAR PHARMACEUTICAL COMPANIES, INC. (PRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Joseph E. Smith's equity in PAR PHARMACEUTICAL COMPANIES, INC.?

Accepted Answer

Joseph E. Smith's equity position in PAR PHARMACEUTICAL COMPANIES, INC. consists of 23,921 shares valued at approximately $0. As Executive, they have executed 44 insider transactions, with $922.5K in purchases and $4.8M in sales.

Question 9

Where can I find Joseph E. Smith's SEC Form 4 filings?

Accepted Answer

All of Joseph E. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph E. Smith has 44 Form 4 filings on record as an insider at PAR PHARMACEUTICAL COMPANIES, INC..

Question 10

What is Joseph E. Smith's net worth from PRX?

Accepted Answer

Based on their current PRX stock holdings, Joseph E. Smith has equity worth approximately $0 in PAR PHARMACEUTICAL COMPANIES, INC.. This value is based on 23,921 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Sep 15, 2017	WBMD	$1.6M	Tender	23,921	$66.50	Discretionary
Dec 5, 2016	WBMD	$1.4M	Sale	25,821

Joseph E. Smith

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Joseph E. Smith Trading Summary

How Much PRX Stock Does Joseph E. Smith Own?

Is Joseph E. Smith Buying or Selling PRX?

Joseph E. Smith's Recent Stock Transactions

Frequently Asked Questions

Track Joseph E. Smith's Trades